Page last updated: 2024-10-22

altretamine and Osteosarcoma

altretamine has been researched along with Osteosarcoma in 2 studies

Altretamine: A hexamethyl-2,4,6-triamine derivative of 1,3,5-triazine.

Osteosarcoma: A sarcoma originating in bone-forming cells, affecting the ends of long bones. It is the most common and most malignant of sarcomas of the bones, and occurs chiefly among 10- to 25-year-old youths. (From Stedman, 25th ed)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hill, GJ1
Johnson, RO1
Metter, G1
Wilson, WL1
Davis, HL1
Grage, T1
Fletcher, WS1
Golomb, FM1
Cruz, AB1
Bielack, S1
Knop, J1
Delling, G1
Winkler, K1

Trials

1 trial available for altretamine and Osteosarcoma

ArticleYear
[Scintigraphic follow-up of osteosarcoma during neoadjuvant chemotherapy. Results of the cooperative osteosarcoma study of the Society for Pediatric Oncology].
    Nuklearmedizin. Nuclear medicine, 1988, Volume: 27, Issue:6

    Topics: Adolescent; Adult; Altretamine; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocol

1988

Other Studies

1 other study available for altretamine and Osteosarcoma

ArticleYear
Multimodal surgical adjuvant therapy for a broad spectrum of tumors in humans.?
    Surgery, gynecology & obstetrics, 1976, Volume: 142, Issue:6

    Topics: Adult; Altretamine; Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Carmustine; Colonic Neo

1976